ALSO READAurobindo Pharma recovers after Wednesday's slide Aurobindo Pharma advances after Q4 results Aurobindo Pharma consolidated net profit declines 4.02% in the March 2017 quarter Aurobindo Pharma standalone net profit rises 10.19% in the March 2017 quarter Aurobindo Pharma acquires Portuguese pharma company - Generis Farmaceutica S.A.
Sales decline 9.99% to Rs 2131.78 croreNet profit of Aurobindo Pharma declined 21.41% to Rs 307.33 crore in the quarter ended June 2017 as against Rs 391.03 crore during the previous quarter ended June 2016.
Sales declined 9.99% to Rs 2131.78 crore in the quarter ended June 2017 as against Rs 2368.41 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales2131.782368.41 -10 OPM %22.0423.92 -PBDT490.01573.42 -15 PBT406.62503.02 -19 NP307.33391.03 -21
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)